Ranked board
Peptides sold to women: who sells them, and what the trials say
Most peptide sellers write to nobody in particular. These are the ones whose own copy addresses women — and three of the five are selling the same molecule, bremelanotide, which is the rare case here where the trials in that population genuinely exist: two completed phase 3 trials in 1,437 premenopausal women underpin an approved product. The claims are still graded as reaching past them, because what those trials measured and what the pages advertise are not the same thing.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
What gets on this board
Every published review with at least one product whose own name or verbatim marketing copy addresses women. Read from the seller's page, never from the brand name — one company here is two sex-segmented brands under one roof and addresses neither audience in the product copy we graded. Only the products addressed to women are counted.
What decides the order
Companies we have a paid relationship with are listed first, and we say so here rather than marking individual rows. Within that group and within the rest, the order is the same measured one: how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Being a partner changes where a company sits, never what its numbers say.
What the grading found
3/17
Claims that match the trials
Across every one of these companies' products sold to women that we have graded.
5/17
Name their pharmacy
A telehealth brand is almost never the pharmacy that fills the order.
1
Publish a readable certificate
Of every company reviewed on this site, not just those on this board.
The ranking
Every product counted here was graded against the published trials for that molecule, using the company's own words about it. The three counts below are that grading, and they are the ranking — there is no score, no weighting and no adjustment behind them.
Only the products whose own copy addresses women are counted here. A company's sex-neutral products are counted on the boards that cover them, and a product addressed to both audiences appears on this board and the men's board alike.
| Company | Claims vs. trials | Discloses | Visit |
|---|---|---|---|
Eden Checked August 2026 | 1/1100%
| Testing shown | Visit |
CoreAge Rx Checked August 2026 | 0/10%
| Nothing published | Visit |
Shed Checked August 2026 | 0/10%
| Nothing published | Visit |
telos rx Checked August 2026 | 1/1100%
| Pharmacy named | Visit |
Prime Doctor RX Checked September 2026 | 1/1100%
| Nothing published | Visit |
Alinwell Checked September 2026 | 0/10%
| Pharmacy namedTesting shownCertificate public | Visit |
Invigor Medical Checked August 2026 | 0/10%
| Pharmacy namedTesting shown | Visit |
PeptidesRx Checked August 2026 | 0/10%
| Pharmacy namedTesting shown | Not linked |
Nex Gen Health Rx Checked September 2026 | 0/10%
| Pharmacy named | Visit |
Lighter You Checked August 2026 | 0/10%
| Testing shown | Visit |
Valhalla Vitality Checked August 2026 | 0/10%
| Testing shown | Visit |
VAULT Men's Health Checked August 2026 | 0/10%
| Testing shown | Not linked |
Believe Health Checked September 2026 | 0/10%
| Nothing published | Visit |
Defy Medical Checked August 2026 | 0/10%
| Nothing published | Visit |
Longevixx Checked September 2026 | 0/10%
| Nothing published | Visit |
NEUVÉ Health Checked September 2026 | 0/10%
| Nothing published | Visit |
SexyMD Checked September 2026 | 0/10%
| Nothing published | Visit |
How a claim is graded, and what moves a compound between evidence tiers, is on our methodology page.
What this board does not measure
Whether it works
A company can describe a weakly-evidenced product accurately and rank well here. What the evidence says about each molecule is on its own graded compound page, and the two questions are deliberately kept apart.
Clinical care
We read public pages. We have not been a patient of any of these companies, have not assessed a consultation, and publish no quality score of any kind.
Price
Prices appear on a review as a note where a company publishes one, and they are not part of this ranking. A cheaper company is not lower here and a dearer one is not higher.
Product quality
Only 1 of the companies reviewed here publish a certificate of analysis a customer can read, and a certificate is not on this board's ranking axis. Nothing here tells you what is in a vial.
Considered, and not on this board
77 companies were inside this board's candidate net and did not meet its rule. Each one has a published review here, and none was left off for an unflattering result.
- 1st Optimal
None of 1st Optimal's 4 product pages addresses women. Its copy for Sermorelin and CJC-1295, Not named — sold only as "peptides", GLP-1 receptor agonist, molecule not named on any page that sells it is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- AgelessRx
None of AgelessRx's 6 product pages addresses women. Its copy for Rapamycin (sirolimus), Semaglutide, Sermorelin, Nicotinamide adenine dinucleotide (NAD+) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- AHBARx
None of AHBARx's 3 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Alan Health
None of Alan Health's 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Andrew Meds
None of Andrew Meds's 2 product pages addresses women. Its copy for GHK-Cu, CJC-1295 and ipamorelin is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Auren Rx
None of Auren Rx's 6 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GHK-Cu, Glutathione and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Belle Health
None of Belle Health's 3 product pages addresses women. Its copy for Semaglutide, Sermorelin, NAD+ is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Bliv
None of Bliv's 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Bodybuilding Health+
None of Bodybuilding Health+'s 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- BreezeMeds
None of BreezeMeds's 4 product pages addresses women. Its copy for NAD+ (nicotinamide adenine dinucleotide), Sermorelin, Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- CareBareRX
None of CareBareRX's 4 product pages addresses women. Its copy for Semaglutide, Tirzepatide, NAD+ (nicotinamide adenine dinucleotide), Sermorelin is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Clume Health
None of Clume Health's 3 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Collective
None of Collective's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- DirectMeds
None of DirectMeds's 4 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- DudeMeds
None of DudeMeds's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Edessa
None of Edessa's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Embody
None of Embody's 2 product pages addresses women. Its copy for Semaglutide or tirzepatide, named only as "GLP-1", Tirzepatide, named only as "GLP-1 / GIP" is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Enhance.MD
None of Enhance.MD's 6 product pages addresses women. Its copy for NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide, Semaglutide and tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Eviora MD
None of Eviora MD's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GLP-1 (molecule not named) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Fella Health
None of Fella Health's 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Found
None of Found's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Gala GLP-1
None of Gala GLP-1's 3 product pages addresses women. Its copy for Tirzepatide, Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- GOAL.MD
None of GOAL.MD's 4 product pages addresses women. Its copy for Semaglutide, Tirzepatide, Sermorelin, Nicotinamide adenine dinucleotide (NAD+) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Goldspan Health
None of Goldspan Health's 6 product pages addresses women. Its copy for Tirzepatide, Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Bremelanotide (PT-141) and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- He & She MD
None of He & She MD's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- HealthRX
None of HealthRX's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Hone Health
None of Hone Health's 5 product pages addresses women. Its copy for Bremelanotide (PT-141), Sermorelin, Nicotinamide adenine dinucleotide (NAD+), Glutathione and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- HumeCare+
None of HumeCare+'s 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Idgie Health
None of Idgie Health's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Joi + Blokes
None of Joi + Blokes's 5 product pages addresses women. Its copy for Tirzepatide, Semaglutide, Sermorelin, Vasoactive intestinal peptide (VIP) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Lean Meds
None of Lean Meds's 2 product pages addresses women. Its copy for Sermorelin, Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Live Vital
None of Live Vital's 7 product pages addresses women. Its copy for BPC-157, TB-500 (thymosin beta-4 fragment), CJC-1295 and ipamorelin, MOTS-c and 3 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- LumiMeds
None of LumiMeds's 2 product pages addresses women. Its copy for Semaglutide, NAD+ is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Luvo Health
None of Luvo Health's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, Longevity program (compounds not named) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Magnolia Regenerative Medicine
None of Magnolia Regenerative Medicine's 8 product pages addresses women. Its copy for BPC-157, TB-500 (thymosin beta-4 fragment), Epithalon, MOTS-c and 4 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- MangoRx
None of MangoRx's 3 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Marek Health
None of Marek Health's 5 product pages addresses women. Its copy for Not named on any reachable page — sold as "therapeutic peptides", BPC-157, Tesamorelin, Elamipretide (SS-31) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Maximus
None of Maximus's 5 product pages addresses women. Its copy for Oxytocin, Sermorelin, Tesamorelin, Semaglutide and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- MEDGm
None of MEDGm's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Mondae
None of Mondae's 3 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- MyDrHank
None of MyDrHank's 3 product pages addresses women. Its copy for Tirzepatide, Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- New Wave Health
None of New Wave Health's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GLP-1 (molecule not named) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- No BS RX
None of No BS RX's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Nova
None of Nova's 3 product pages addresses women. Its copy for Tesamorelin, NAD+ (nicotinamide adenine dinucleotide), Sermorelin is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- NovoCare Pharmacy
None of NovoCare Pharmacy's 4 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Oak Longevity
None of Oak Longevity's 4 product pages addresses women. Its copy for Sermorelin, Tesamorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Oria Meds
None of Oria Meds's 2 product pages addresses women. Its copy for Semaglutide, NAD+ (nicotinamide adenine dinucleotide) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Pallas Health
None of Pallas Health's 4 product pages addresses women. Its copy for NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Peak Wellness
None of Peak Wellness's 1 product pages addresses women. Its copy for Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Polly (formerly Piper)
None of Polly (formerly Piper)'s 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Regenics
None of Regenics's 6 product pages addresses women. Its copy for Tesamorelin, BPC-157, Epithalon (epitalon), MOTS-c and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Rehydra+ Wellness
None of Rehydra+ Wellness's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, Nicotinamide adenine dinucleotide (NAD+) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Renlo Health
None of Renlo Health's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- RX Bella
None of RX Bella's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GLP-1 (molecule not named) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Rx.com
None of Rx.com's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- RxSpan MD
None of RxSpan MD's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Science & Co
None of Science & Co's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Sesame Care
None of Sesame Care's 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- SkinnyRx
None of SkinnyRx's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- SnagRx
None of SnagRx's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Solaya MD
None of Solaya MD's 3 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Sprout Health
None of Sprout Health's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Strut Health
None of Strut Health's 6 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Semaglutide, Tirzepatide and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Superior Remedies
None of Superior Remedies's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Synergy Rx
None of Synergy Rx's 11 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione, Bremelanotide (PT-141) and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- The Edit Health
None of The Edit Health's 6 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GHK-Cu, Sermorelin and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- TOM Weight Loss
None of TOM Weight Loss's 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Transcend
None of Transcend's 6 product pages addresses women. Its copy for Tesamorelin, Tesofensine, Semaglutide, GHK-Cu and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Trava Health
None of Trava Health's 1 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Trellis Vitality
None of Trellis Vitality's 5 product pages addresses women. Its copy for Semaglutide, Tirzepatide, Tesamorelin, Nicotinamide adenine dinucleotide (NAD+) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Trimi
None of Trimi's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Try Ageless
None of Try Ageless's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- VevaRX
None of VevaRX's 4 product pages addresses women. Its copy for Sermorelin, NAD+ (nicotinamide adenine dinucleotide), Glutathione, Bremelanotide (PT-141) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Vyvron
None of Vyvron's 5 product pages addresses women. Its copy for Sermorelin, Nicotinamide adenine dinucleotide (NAD+), Methylcobalamin with methionine, inositol and choline (B12-MIC), Semaglutide and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- WellMedr
None of WellMedr's 6 product pages addresses women. Its copy for Tirzepatide with NAD+ and vitamin B12, Semaglutide with NAD+ and vitamin B12, Tirzepatide with NAD+, L-carnitine and vitamin B12, Tirzepatide and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- Wellorithm
None of Wellorithm's 2 product pages addresses women. Its copy for Semaglutide, Tirzepatide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
- yourEra
None of yourEra's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GLP-1 microdose (molecule not named) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.
Frequently asked questions
Is this board claiming a compound acts differently by sex?
No, and nothing on this site does. We have no cited trial showing a sex difference for any compound here, so we make no such claim. What this board reports is narrower and entirely checkable: which companies write to women on their own product pages, and whether the claim made there survives the trials behind that molecule.
Why is a company missing when it clearly treats women?
Because it never says so on a product page. Nearly every company on this site will treat anyone its licensing allows; most of them just write copy addressed to nobody. The register below names every company that was considered and did not qualify, with what its pages actually say, so absence here is never mistaken for exclusion there.
Nothing pinned
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.